FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088358463> ?p ?o ?g. }

• W2088358463 endingPage "1928" @default.
• W2088358463 startingPage "1921" @default.
• W2088358463 abstract "BackgroundThe role of multimodality therapy in stage IIIB non–small cell lung cancer (NSCLC) remains inadequately studied. Although chemoradiation is currently the mainstay of treatment, randomized trials evaluating surgical intervention are lacking, and resection is offered selectively.MethodsData from patients with clinical stage IIIB NSCLC (T4N2 or any N3) undergoing definitive multimodality therapy were obtained from the National Cancer Database (NCDB). Multivariable Cox regression models were fitted to evaluate variables influencing overall survival (OS).ResultsFrom 1998 to 2010, 7,459 patients with clinical stage IIIB NSCLC were treated with definitive chemoradiation (CR group), whereas 1,714 patients underwent chemotherapy, radiation, and surgical intervention in any sequence (CRS group). CRS patients were more likely to be younger and white and have slightly smaller tumors (all p < 0.01). There was no difference in Charlson Comorbidity Index (CCI) between the groups (p = 0.5). In the CRS group, 79% of patients received neoadjuvant therapy. Thirty-day surgical mortality was 3%. Factors associated with improved OS in multivariate analysis included younger age, female sex, decreased CCI, smaller tumor size, and surgical resection (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.52–0.63). Among patients treated with surgical intervention, incomplete resection was associated with decreased OS (HR, 1.52; 95% CI, 1.20–1.92). Median OS was longer in the CRS group (25.9 months versus 16.3 months; p < 0.001). Propensity matched analysis on 631 patient pairs treated with CRS versus CR confirmed these findings (median OS, 28.9 versus 17.2 months; p < 0.001).ConclusionsSurgical resection as a part of multimodality therapy may be associated with improved OS in highly selected patients with stage IIIB NSCLC. Multidisciplinary evaluation of these patients is critical. The role of multimodality therapy in stage IIIB non–small cell lung cancer (NSCLC) remains inadequately studied. Although chemoradiation is currently the mainstay of treatment, randomized trials evaluating surgical intervention are lacking, and resection is offered selectively. Data from patients with clinical stage IIIB NSCLC (T4N2 or any N3) undergoing definitive multimodality therapy were obtained from the National Cancer Database (NCDB). Multivariable Cox regression models were fitted to evaluate variables influencing overall survival (OS). From 1998 to 2010, 7,459 patients with clinical stage IIIB NSCLC were treated with definitive chemoradiation (CR group), whereas 1,714 patients underwent chemotherapy, radiation, and surgical intervention in any sequence (CRS group). CRS patients were more likely to be younger and white and have slightly smaller tumors (all p < 0.01). There was no difference in Charlson Comorbidity Index (CCI) between the groups (p = 0.5). In the CRS group, 79% of patients received neoadjuvant therapy. Thirty-day surgical mortality was 3%. Factors associated with improved OS in multivariate analysis included younger age, female sex, decreased CCI, smaller tumor size, and surgical resection (hazard ratio [HR], 0.57; 95% confidence interval [CI], 0.52–0.63). Among patients treated with surgical intervention, incomplete resection was associated with decreased OS (HR, 1.52; 95% CI, 1.20–1.92). Median OS was longer in the CRS group (25.9 months versus 16.3 months; p < 0.001). Propensity matched analysis on 631 patient pairs treated with CRS versus CR confirmed these findings (median OS, 28.9 versus 17.2 months; p < 0.001). Surgical resection as a part of multimodality therapy may be associated with improved OS in highly selected patients with stage IIIB NSCLC. Multidisciplinary evaluation of these patients is critical." @default.
• W2088358463 created "2016-06-24" @default.
• W2088358463 creator A5018238156 @default.
• W2088358463 creator A5026052001 @default.
• W2088358463 creator A5031201037 @default.
• W2088358463 creator A5031420337 @default.
• W2088358463 creator A5033896136 @default.
• W2088358463 creator A5048361872 @default.
• W2088358463 creator A5052508193 @default.
• W2088358463 creator A5055841327 @default.
• W2088358463 creator A5080011474 @default.
• W2088358463 creator A5083473334 @default.
• W2088358463 creator A5087238978 @default.
• W2088358463 creator A5088902979 @default.
• W2088358463 creator A5091063212 @default.
• W2088358463 date "2015-06-01" @default.
• W2088358463 modified "2023-09-26" @default.
• W2088358463 title "Role for Surgical Resection in the Multidisciplinary Treatment of Stage IIIB Non–Small Cell Lung Cancer" @default.
• W2088358463 cites W1817196311 @default.
• W2088358463 cites W1939536288 @default.
• W2088358463 cites W1986794774 @default.
• W2088358463 cites W1997728054 @default.
• W2088358463 cites W2031773498 @default.
• W2088358463 cites W2038952002 @default.
• W2088358463 cites W2040907987 @default.
• W2088358463 cites W2060524271 @default.
• W2088358463 cites W2088720324 @default.
• W2088358463 cites W2115721892 @default.
• W2088358463 cites W2153865661 @default.
• W2088358463 cites W2156857693 @default.
• W2088358463 cites W2157504792 @default.
• W2088358463 cites W2585613986 @default.
• W2088358463 cites W4251929212 @default.
• W2088358463 cites W4293873735 @default.
• W2088358463 cites W4383858999 @default.
• W2088358463 cites W80249730 @default.
• W2088358463 cites W2105745036 @default.
• W2088358463 doi "https://doi.org/10.1016/j.athoracsur.2015.02.033" @default.
• W2088358463 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4562377" @default.
• W2088358463 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25912748" @default.
• W2088358463 hasPublicationYear "2015" @default.
• W2088358463 type Work @default.
• W2088358463 sameAs 2088358463 @default.
• W2088358463 citedByCount "25" @default.
• W2088358463 countsByYear W20883584632016 @default.
• W2088358463 countsByYear W20883584632017 @default.
• W2088358463 countsByYear W20883584632018 @default.
• W2088358463 countsByYear W20883584632019 @default.
• W2088358463 countsByYear W20883584632020 @default.
• W2088358463 countsByYear W20883584632021 @default.
• W2088358463 countsByYear W20883584632022 @default.
• W2088358463 countsByYear W20883584632023 @default.
• W2088358463 crossrefType "journal-article" @default.
• W2088358463 hasAuthorship W2088358463A5018238156 @default.
• W2088358463 hasAuthorship W2088358463A5026052001 @default.
• W2088358463 hasAuthorship W2088358463A5031201037 @default.
• W2088358463 hasAuthorship W2088358463A5031420337 @default.
• W2088358463 hasAuthorship W2088358463A5033896136 @default.
• W2088358463 hasAuthorship W2088358463A5048361872 @default.
• W2088358463 hasAuthorship W2088358463A5052508193 @default.
• W2088358463 hasAuthorship W2088358463A5055841327 @default.
• W2088358463 hasAuthorship W2088358463A5080011474 @default.
• W2088358463 hasAuthorship W2088358463A5083473334 @default.
• W2088358463 hasAuthorship W2088358463A5087238978 @default.
• W2088358463 hasAuthorship W2088358463A5088902979 @default.
• W2088358463 hasAuthorship W2088358463A5091063212 @default.
• W2088358463 hasBestOaLocation W20883584632 @default.
• W2088358463 hasConcept C121608353 @default.
• W2088358463 hasConcept C126322002 @default.
• W2088358463 hasConcept C141071460 @default.
• W2088358463 hasConcept C146357865 @default.
• W2088358463 hasConcept C151730666 @default.
• W2088358463 hasConcept C168563851 @default.
• W2088358463 hasConcept C207103383 @default.
• W2088358463 hasConcept C2776256026 @default.
• W2088358463 hasConcept C2776694085 @default.
• W2088358463 hasConcept C2779159551 @default.
• W2088358463 hasConcept C44249647 @default.
• W2088358463 hasConcept C50382708 @default.
• W2088358463 hasConcept C509974204 @default.
• W2088358463 hasConcept C71924100 @default.
• W2088358463 hasConcept C86803240 @default.
• W2088358463 hasConceptScore W2088358463C121608353 @default.
• W2088358463 hasConceptScore W2088358463C126322002 @default.
• W2088358463 hasConceptScore W2088358463C141071460 @default.
• W2088358463 hasConceptScore W2088358463C146357865 @default.
• W2088358463 hasConceptScore W2088358463C151730666 @default.
• W2088358463 hasConceptScore W2088358463C168563851 @default.
• W2088358463 hasConceptScore W2088358463C207103383 @default.
• W2088358463 hasConceptScore W2088358463C2776256026 @default.
• W2088358463 hasConceptScore W2088358463C2776694085 @default.
• W2088358463 hasConceptScore W2088358463C2779159551 @default.
• W2088358463 hasConceptScore W2088358463C44249647 @default.
• W2088358463 hasConceptScore W2088358463C50382708 @default.
• W2088358463 hasConceptScore W2088358463C509974204 @default.
• W2088358463 hasConceptScore W2088358463C71924100 @default.
• W2088358463 hasConceptScore W2088358463C86803240 @default.
• W2088358463 hasIssue "6" @default.

• next